Expertise in
2
conditions

Jean Y. Blay

Lyon, FR 
Expertise in
2
conditions
Lyon, FR 

Overview

Jean Blay practices practicing medicine in Lyon, France.

Ms. Blay is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Chondrosarcoma, Gastrointestinal Stromal Tumor, and Desmoid Tumor.

She is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Lyon, France
Other Locations
Gustave Roussy, Villejuif, 114, Rue Edouard Vaillant, Villejuif, 94805, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor
Enrollment Status: Completed
Publish Date: August 07, 2026
Intervention Type: Drug
Study Drugs: Ramucirumab, Cyclophosphamide, Vinorelbine
Study Phase: Phase 1/Phase 2
Phase II Study on TSR-042 in Advanced Clear Cell Sarcoma
Phase II Study on TSR-042 in Advanced Clear Cell Sarcoma
Enrollment Status: Terminated
Publish Date: February 01, 2024
Intervention Type: Drug
Study Drug: TSR-042
Study Phase: Phase 2
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma
Enrollment Status: Terminated
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drugs: Ramucirumab, Gemcitabine, Docetaxel
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

39 Total Publications

An evaluation of afamitresgene autoleucel for the treatment of advanced synovial sarcoma and myxoid round cell liposarcoma.
An evaluation of afamitresgene autoleucel for the treatment of advanced synovial sarcoma and myxoid round cell liposarcoma.
Journal: Expert review of anticancer therapy
Published: December 31, 2025

Frequently Asked Questions about Jean Y. Blay

Is Jean Y. Blay a top-rated expert for Adult Soft Tissue Sarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Jean Y. Blay is classified as an Advanced expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean Y. Blay participate in research or clinical trials?

Yes. Jean Y. Blay has published 39 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Jean Y. Blay's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Blay's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile